On Wednesday (02/09/2020) Indonesia Investments released the August 2020 edition of its monthly report. In this edition, titled 'In Search of a Vaccine', we discuss the efforts that are being made in Indonesia to deliver a safe and reliable vaccine for the COVID-19 virus and provide an overview of Indonesia's pharmaceutical industry.
Update COVID-19 in Indonesia: 927,380 confirmed infections, 26,590 deaths (19 January 2021)
19 January 2021 (closed)
USD/IDR (14,146) -6.00 -0.04%
EUR/IDR (17,335) +57.05 +0.33%
Jakarta Composite Index (6,321.86) -67.98 -1.06%
The Today's Headlines section of Indonesia Investments is a daily updated section which contains the latest information with regard to topics that are currently causing headlines in Indonesia's media. Most of our headlines will cover political, economic and social matters. As a consequence of their recent nature, these topics may not have crystallized fully yet and can, therefore, lack a profound analysis. For publications with a more in-depth understanding of subjects, we refer you to our News, Financial or Business columns.
Based on the latest data from the Indonesia Investment Coordinating Board (BKPM), total investment realization in Indonesia fell 4.3 percent year-on-year (y/y) in the second quarter of 2020 (these data do not include investment in the banking and oil and gas sectors). The decline is attributed to the COVID-19 crisis that has paralyzed the global and domestic economies.
While Indonesia’s manufacturing activity has remained contracting in July 2020 as a result of the COVID-19 crisis that seriously disrupts consumption, production and trade flows, the positive news is that the rate of contraction eased significantly.
The novel coronavirus (COVID-19) pandemic brings unusual times for any country, especially in terms of the economic and social environments. In the case of Indonesia it has triggered historically low headline inflation, namely 1.54 percent year-on-year (y/y) after July 2020 brought deflation of -0.10 percent month-on-month (m/m).